A Phase III Stratified, Remdomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immumogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-adjuvanted Comparator

  • Fling, John (PI)

Project Details

StatusFinished
Effective start/end date28/10/14 → 31/10/19

Funding

  • Novartis Pharmaceuticals: $1,192,511.69

Keywords

  • Biotechnology & Drug Development, Infectious Diseases